AAAAAA
Results:
1-17
|
Results: 17
Authors:
Dempke, W
Schmoll, HJ
Citation: W. Dempke et Hj. Schmoll, Possible new indications for the treatment with erythropoietin, MED KLIN, 96(8), 2001, pp. 467-474
Authors:
Dempke, W
Rie, C
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Cyclooxygenase-2: a novel target for cancer chemotherapy?, J CANC RES, 127(7), 2001, pp. 411-417
Authors:
Dempke, W
Voigt, W
Grothey, A
Hill, BT
Schmoll, HJ
Citation: W. Dempke et al., Cisplatin resistance and oncogene - a review, ANTI-CANC D, 11(4), 2000, pp. 225-236
Authors:
von Poblozki, A
Dempke, W
Schmoll, HJ
Citation: A. Von Poblozki et al., Carboxypeptidase-G2 rescue in a patient with MTX-induced renal failure, MED KLIN, 95(8), 2000, pp. 457-460
Authors:
Dempke, W
Citation: W. Dempke, Concerning: Dempke et al.: Therapeutic management of pleural and pericardial effusions. Onkologie 1999;22 : 526-529 - Reply, ONKOLOGIE, 23(2), 2000, pp. 176-176
Authors:
Kellner, O
Voigt, W
Schneyer, U
Dempke, W
Schmoll, HJ
Citation: O. Kellner et al., HCG induced hyperthyreosis in germ cell cancer, ANTICANC R, 20(6D), 2000, pp. 5135-5138
Authors:
Dempke, W
Von Poblozki, A
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Human hematopoietic growth factors: Old lessons and new perspectives, ANTICANC R, 20(6D), 2000, pp. 5155-5164
Authors:
Dempke, W
von Poblozki, A
Kellner, O
Wolf, HH
Schmoll, HJ
Citation: W. Dempke et al., Hemorrhagic disorder as initial manifestation of metastatic gastric cancer, WIEN KLIN W, 112(24), 2000, pp. 1053-1058
Authors:
Kellner, O
Dempke, W
Schmoll, HJ
Citation: O. Kellner et al., Glucose infusions - Possible effective treatment option in Ifosfamide-induced encephalopathy, DEUT MED WO, 124(37), 1999, pp. 1086-1087
Authors:
Dempke, W
Voigt, W
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin, ANTI-CANC D, 10(6), 1999, pp. 545-549
Authors:
Dempke, W
Behrmann, C
Schober, C
Buchele, T
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Diagnostic and therapeutic management of superior vena cava syndrome, MED KLIN, 94(12), 1999, pp. 681-684
Authors:
Dempke, W
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Therapeutic management of pleural and pericardial effusions, ONKOLOGIE, 22(6), 1999, pp. 526-529
Authors:
Grothey, A
Voigt, W
Schober, C
Muller, T
Dempke, W
Schmoll, HJ
Citation: A. Grothey et al., The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors, J CANC RES, 125(3-4), 1999, pp. 166-173
Authors:
Schmoll, HJ
Buchele, T
Grothey, A
Dempke, W
Citation: Hj. Schmoll et al., Where do we stand with 5-fluorouracil?, SEMIN ONCOL, 26(6), 1999, pp. 589-605
Authors:
Firusian, N
Dempke, W
Citation: N. Firusian et W. Dempke, An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases, CANCER, 85(4), 1999, pp. 980-987
Authors:
Dempke, W
Firusian, N
Citation: W. Dempke et N. Firusian, Treatment of malignant pericardial effusion with P-32-colloid, BR J CANC, 80(12), 1999, pp. 1955-1957
Authors:
Dempke, W
Firusian, N
Citation: W. Dempke et N. Firusian, Unusual course of a hemangiopericytoma, MED KLIN, 93(12), 1998, pp. 726-728
Risultati:
1-17
|